Apoptosis/NN
mediated/VBN
by/IN
HIV/NN
protease/NN
is/VBZ
preceded/VBN
by/IN
cleavage/NN
of/IN
Bcl-2/NN
./.

Expression/NN
of/IN
the/DT
human/JJ
immunodeficiency/NN
virus/NN
type/NN
1/CD
(/(
HIV/NN
)/)
protease/NN
in/IN
cultured/VBN
cells/NNS
leads/VBZ
to/TO
apoptosis/NN
,/,
preceded/VBN
by/IN
cleavage/NN
of/IN
bcl-2/NN
,/,
a/DT
key/JJ
negative/JJ
regulator/NN
of/IN
cell/NN
death/NN
./.
=====
In/IN
contrast/NN
,/,
a/DT
high/JJ
level/NN
of/IN
bcl-2/NN
protects/VBZ
cells/NNS
in/FW
vitro/FW
and/CC
in/FW
vivo/FW
from/IN
the/DT
viral/JJ
protease/NN
and/CC
prevents/VBZ
cell/NN
death/NN
following/VBG
HIV/NN
infection/NN
of/IN
human/JJ
lymphocytes/NNS
,/,
while/IN
reducing/VBG
the/DT
yields/NNS
of/IN
viral/JJ
structural/JJ
proteins/NNS
,/,
infectivity/NN
,/,
and/CC
tumor/NN
necrosis/NN
factor/NN
alpha/NN
./.
=====
We/PRP
present/VBP
a/DT
model/NN
for/IN
HIV/NN
replication/NN
in/IN
which/WDT
the/DT
viral/JJ
protease/NN
depletes/VBZ
the/DT
infected/JJ
cells/NNS
of/IN
bcl-2/NN
,/,
leading/VBG
to/TO
oxidative/JJ
stress-dependent/JJ
activation/NN
of/IN
NF/NN
kappa/NN
B/NN
,/,
a/DT
cellular/JJ
factor/NN
required/VBN
for/IN
HIV/NN
transcription/NN
,/,
and/CC
ultimately/RB
to/TO
cell/NN
death/NN
./.
=====
Purified/VBN
bcl-2/NN
is/VBZ
cleaved/VBN
by/IN
HIV/NN
protease/NN
between/IN
phenylalanine/NN
112/CD
and/CC
alanine/NN
113/CD
./.
=====
The/DT
results/NNS
suggest/VBP
a/DT
new/JJ
option/NN
for/IN
HIV/NN
gene/NN
therapy/NN
;/:
bcl-2/NN
muteins/NNS
that/WDT
have/VBP
noncleavable/JJ
alterations/NNS
surrounding/VBG
the/DT
HIV/NN
protease/NN
cleavage/NN
site/NN
./.